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Abstract
To elucidate the relationship between intragenic DNA methylation and chromatin marks, we performed epigenetic profiling
of chromosome 19 in human bronchial epithelial cells (HBEC) and in the colorectal cancer cell line HCT116 as well as its
counterpart with double knockout of DNMT1 and DNMT3B (HCT116-DKO). Analysis of H3K36me3 profiles indicated that this
intragenic mark of active genes is associated with two categories of genes: (i) genes with low CpG density and H3K9me3 in
the gene body or (ii) genes with high CpG density and DNA methylation in the gene body. We observed that a combination
of low CpG density in gene bodies together with H3K9me3 and H3K36me3 occupancy is a specific epigenetic feature of zinc
finger (ZNF) genes, which comprise 90% of all genes carrying both histone marks on chromosome 19. For genes with high
intragenic CpG density, transcription and H3K36me3 occupancy were not changed in conditions of partial or intensive loss
of DNA methylation in gene bodies. siRNA knockdown of SETD2, the major histone methyltransferase responsible for
production of H3K36me3, did not reduce DNA methylation in gene bodies. Our study suggests that the H3K36me3 and
DNA methylation marks in gene bodies are established largely independently of each other and points to similar functional
roles of intragenic DNA methylation and intragenic H3K9me3 for CpG-rich and CpG-poor genes, respectively.
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Introduction
Methylation of cytosines at promoters is an epigenetic mark,
which is linked to gene silencing. The main regulatory function of
DNA methylation has been associated with CpG-rich regions,
CpG islands, which are frequently co-localized with gene
promoters. It is well known that DNA methylation prevents
binding of a number of transcription factors and attracts
methylated-CpG binding domain proteins (MBDs) together with
chromatin modifiers, which are responsible for the repressive
chromatin structure [1]. In contrast to unmethylated promoters,
repetitive elements are usually hypermethylated in normal cells
whereas loss of repetitive DNA methylation has been linked to
chromosomal instability and cancer [2,3]. The mechanisms that
control the inherently non-sequence-specific DNA (cytosine-5-)-
methyltransferases (DNMTs) and establish a particular DNA
methylation pattern along the genome are still unclear.
Connections between DNA methylation and chromatin mod-
ification processes have recently become apparent. Aberrant CpG
island DNA methylation in cancer has been linked to the
Polycomb-associated repressive histone mark, H3K27me3
[4,5,6]. This histone mark or its associated Polycomb components
predispose target sequences to DNA methylation, for example
during aging, inflammation and carcinogenesis [6,7,8,9]. Di- and
tri-methylated H3K9 (H3K9me2 and H3K9me3) are frequently
found at aberrantly methylated gene promoters [5,10]. It has been
shown that H3K9 methylation promotes DNA methylation in
Arabidopsis thaliana,i nNeurospora crassa and in mammalian
heterochromatin repeats [11,12,13]. Moreover, the H3K9 meth-
yltransferase, SUV39H1 interacts with DNA (cytosine-5-)-methyl-
transferase 1 (DNMT1) and due to a common interaction partner,
HP1, SUV39H1 can be found in the same complex with the de
novo DNA methyltransferase, DNMT3B [12,14,15,16]. Also,
SETDB1, a methyltransferase that produces H3K9me3, has been
detected in complex with the de novo DNA methyltransferase,
DNMT3A [17].
Recently, a number of publications reported on the presence of
extensive DNA methylation in gene bodies, downstream of
transcription start sites (intragenic methylation). It was noticed
that actively transcribed genes are associated with increased DNA
methylation levels in Arabidopsis thaliana [18,19] and in mammals
[20,21,22]. In fact, in human cells most of the DNA methylation
peaks are found in gene bodies rather than in promoters [22].
Inter- and intragenic CpG islands are preferentially susceptible to
DNA methylation [23]. These findings indicate a possible new
universal function of DNA methylation. Furthermore, it was
observed that the transcription elongation mark, H3K36me3, is
often correlated with DNA hypermethylation [24]. This histone
modification is mainly established due to SETD2 histone
methyltransferase activity [25,26]. SETD2 forms a complex with
hyperphosphorylated RNA polymerase II during elongation
[26,27]. The functional role of DNA methylation in transcription
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It has been proposed that DNA methylation may inhibit initiation
of aberrant transcription [28] and this function could be
particularly important in gene bodies [18,22]. A similar role is
proposed for the H3K36me3 modification [29].
To more precisely understand the crosstalk between histone
modifications, DNA methylation and transcription in mammalian
cells, we profiled DNA methylation and chromatin modifications
on human chromosome 19 in human bronchial epithelial cells
(HBEC). To understand the impact of DNA methylation on
chromatin and transcription, we performed a similar analysis in
the HCT116 colon cancer cell line with double knockout of
DNMT1 and DNMT3B, a cell line characterized by loss of 95%
of DNA methylation [30]. To identify a role of H3K36me3 in
establishing DNA methylation patterns in gene bodies, we
analyzed epigenetic changes in cells lacking SETD2 after
siRNA-mediated knockdown of SETD2.
Results
Crosstalk between histone modifications and DNA
methylation on chromosome 19
To understand the interdependence between DNA methylation
and histone modifications, we profiled DNA methylation patterns
and several histone modifications along human chromosome 19
(chr19) on NimbleGen tiling arrays in human bronchial epithelial
cells immortalized with hTERT and CDK4 [31]. Chromosome 19
was chosen because of its high gene density and CpG methylation
frequency [22]. These data sets were compared to expression
profiles obtained on the Affymetrix platform. DNA methylation
patterns were analyzed by using two complementary methods, the
UnMethylCollector
TM (UMC) method, here applied for the first
time to genome-wide profiling of unmethylated CpGs on tiling
arrays, and the methylated-CpG island recovery assay (MIRA).
Whereas UMC enriches the unmethylated DNA fraction of the
genome due to the high affinity of the CXXC domain of the
MBD1 protein to unmethylated CpGs [23,32], MIRA is used to
enrich methylated genomic DNA fragments by using the protein
complex of MBD2B and MBD3L1 [22,33]. The combination of
both assays allows us to comprehensively map DNA methylation
patterns along chromosomes. These methylation patterns were
then compared to H3K27me3, H3K9me3, H3K9/K14 acetyla-
tion and H3K36me3 histone modification profiles.
The distribution of epigenetic marks over all genes of chr19
(Figure 1) showed that the DNA methylation signal (MIRA)
generally is opposite to the unmethylated CpG (UMC) signal (see
also Figure S1G). For most genes, DNA methylation also inversely
correlates with the repressive histone marks H3K9me3 and
H4K20me3. It is apparent that the DNA methylation level is
often high in genes showing H3K36me3 enrichment consistent
with previous results [20,22,24]. Analysis of signals within gene
bodies of chr19 genes indicates co-localization of DNA methyl-
ation and H3K36me3 (Figure 1; Figure 2A,B,C). Gene body was
defined as the entire gene from the transcription start site to the
end of the transcript. Absence of H3K36me3 was associated with
partial methylation or hypomethylation status of gene body DNA
as indicated by UMC signal (Figure 1). Genes carrying both
intragenic DNA methylation and H3K36me3 are sharply
unmethylated at the promoter and hypermethylated within the
gene body (Figure 1; Figure 2B,C). They also show acetylated
histone H3 near their 59 ends (Figure 1). At the 39 end of genes, in
H3K36me3-free areas, we observed a loss of DNA methylation by
using both methods, MIRA and UMC (Figure 1; Figure 2B,C).
This finding was confirmed by combined bisulfite restriction
analysis (COBRA) for the LSM4 gene (Figure S1A). These
observations indicate a strong link between H3K36me3 and
DNA methylation since absence of H3K36me3 is immediately
reflected in reduction of DNA methylation. We further validated
the correlation between H3K36me3 and gene body DNA
methylation with additional COBRA methylation assays for the
POLD1 and NFKBIB genes (Figure S1B,C).
The plotting of unmethylated DNA peaks mapped by UMC
versus histone H3 acetylation and H3K36me3 modifications
showed that unmethylated DNA is enriched for H3 acetylation but
is reverse to H3K36me3 (Figure 2C). The profiling of other
epigenetic marks indicated that genes carrying H3K36me3 and
DNA methylation in the gene body contain very low levels of
H3K27me3, H3K9me3 and H4K20me3 (Figure 1; Figure 2B,C).
We then performed correlative analysis of DNA methylation and
H3K36me3 signals within gene bodies (Figure S1D,E). For these
genes, plotting the MIRA signal in gene bodies versus H3K36me3
showed a Pearson correlation coefficient of R=0.38 (p,0.001)
whereas the UMC signal was negatively correlated with
H3K36me3 (R=-0.39; p,0.001). The data sets suggest that
presence of H3K36me3 is associated with an increase of DNA
methylation in gene bodies and absence of H3K36me3 is
associated with reduced levels of methylated DNA. Histone H3
acetylation or unmethylated CpGs were also negatively correlated
with the MIRA signal (Figure S1F,G; P,0.00001).
Clustering analysis of epigenetic profiles of gene bodies showed
that a subset of gene-specific DNA methylation patterns generated
by MIRA is also associated with the Polycomb mark H3K27me3
(Figure 1; Figure S2A). H3K27me3-covered genes are repressed
according to mRNA expression data and characterized by absence
of the H3K36me3 mark and by the presence of both MIRA and
UMC signals along the gene body (Figure 1; Figure S2B,C).
Comparison of the two gene groups, genes covered by H3K27me3
and by DNA methylation covering at least 20% of gene body
length and genes harboring H3K36me3 and DNA methylation
over at least 20% of gene body length, showed that the DNA
methylation level is higher in genes with H3K36me3 and DNA
methylation than in genes with H3K27me3 and DNA methylation
and both groups are characterized by equal CpG density in gene
bodies (Figure S2D,E).
Gene bodies of zinc finger genes are enriched in
H3K9me3 and H3K36me3
The H3K9me3 profile showed that this epigenetic mark
strongly co-localizes with the other repressive mark, H4K20me3
(Figure 1). Similar to the group of H3K27me3-covered genes,
genes associated with H3K9me3 have low levels of transcription.
H3K9me3-covered gene bodies are generally CpG poor
(Figure 3A). Only occasional spots of H3K9me3 enrichment can
be found in gene bodies with average or high CpG density. Gene
bodies of H3K9me3-associated genes have low levels of transcrip-
tion, and either low CpG content or low levels of DNA
methylation as indicated by a UMC signal (Figure 1). Analysis
of DNA methylation status by COBRA confirmed the presence of
unmethylated DNA or partially methylated DNA in gene bodies of
several H3K9me3-covered genes, including NALP11, UNC13A
and ZNF563 (Figure S3A). Analysis of the H3K9me3-covered
genes showed that these genes are characterized by specific zinc
finger motifs according to DAVID analysis (Figure S3B) [34].
Strikingly, from 382 genes covered by H3K9me3 on chr19, 62%
are zinc finger (ZNF) genes (Figure 1). Chr19 carries the highest
number of ZNF genes in comparison to the other human
chromosomes (Figure 3B). Forty-four percent (334 of 755) of all
ZNF genes are located on chr19.
DNA Methylation and Chromatin Marks in Gene Bodies
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mark. However, we found that some genes in H3K9me3 blocks
harbor also the H3K36me3 modification typical of transcribed
genes (Figure 1; Figure 3C,D). Ninety percent of the 193 dual-
occupied genes are zinc finger protein encoding genes (Figure 3E).
Most of the ZNF genes carry H3K36me3 in bronchial epithelial
cells but they are characterized by a low level of expression in
comparison to other genes (Figure 1). This level of transcription is
comparable to that of H3K27me3-repressed genes. However, in
contrast to H3K27me3-associated genes, ZNF genes are occupied
by H3K36me3. ZNF gene promoters are frequently associated
with high CpG density sequences (CpG islands), in contrast to
their gene bodies, which have low CpG density. For most active
ZNF genes, promoters are marked by unmethylated DNA
according to the UMC and MIRA profiles and by histone
acetylation (Figure 1; Figure 3C,D). We did not observe any
H3K27me3 enrichment in gene bodies of ZNF genes.
Our data indicate that 78% of all genes with the H3K36me3
mark are associated with intragenic DNA hypermethylation
whereas 17% of the H3K36me3-marked genes carry H3K9me3
in their gene body (Figure 3F). Based on our criteria for gene
coverage, these numbers add up to almost 100% for all
H3K36me3-associated genes on chr19 and are indicating possible
links between high CpG density and DNA hypermethylation in
one class of genes and between low CpG density and H3K9me3 in
the gene bodies of the other class of genes.
The relationship between H3K36me3 and DNA methylation
and between H3K36me3 and H3K9me3 was further analyzed
within genes of different expression levels and with respect to
exon-intron structure (Figure S4). Expression data from Affymetrix
exon arrays were used in this analysis. Again, we subdivided the
genes into two categories: genes covered by H3K36me3 and CpG
methylation (MIRA) (Figure S4A,B) and genes covered by
H3K36me3 and H3K9me3 (Figure S4C,D). These data show
that the exons of the more highly expressed genes carry higher
levels of H3K36me3 for both categories of genes. On the other
hand, the MIRA signal is stronger for genes with higher expression
levels while the H3K9me3 signal does not correlate with
expression levels in the other category of genes. When examining
all exons combined, we did not find much difference between
exons and introns for genes co-occupied either by DNA
methylation (MIRA signal) and H3K36me3 (Figure S4A,B) or
by H3K36me3 and H3K9me3 (Figure S4C,D) although the
H3K9me3 signal was slightly lower in introns. We also looked at
DNA methylation, H3K36me3 and H3K9me3 at the first and last
exons and at the first and last coding exons, respectively, in genes
with low and high expression levels, respectively (Figure S4). All
three modifications were generally lower at the first exons but
increased at the first coding exons. We think this is because many
genes have 59 untranslated first exons, which often fall within the
CpG islands near their promoters. CpG islands are generally
devoid of these repressive modifications.
DNA methylation and H3K36me3 histone marks in
HCT116 cells deficient in DNMT1 and DNMT3B
Since our data indicated a strong link between DNA
methylation and the H3K36me3 mark, we investigated epigenetic
profiles in the HCT116 colorectal cancer cell line and in its
isogenic counterpart with double knockout of DNMT1 and
DNMT3B [30]. As reported, 95% of DNA methylation is lost in
this cell line. By using the COBRA method, we confirmed almost
complete loss of DNA methylation in repetitive LINE1 elements in
HCT116-DKO cells in comparison to the original cell line (Figure
S5A). We profiled DNA methylation, H3K9me3, H3K36me3 and
transcripts (by cDNA hybridization) in HCT116 and HCT116-
DKO cells along chr19. These data were also compared to results
from Affymetrix exon arrays. To evaluate the epigenetic changes
in the DNMT1 gene itself caused by disruption of exons 3-5, we
examined the epigenetic profile of the DNMT1 locus located on
chr19 (Figure S5B). We identified H3K36me3 occupancy in
HCT116-DKO cells with loss of signal for the deleted exons 3 to
5. Also, analysis of Affymetrix exon arrays indicated a 2.5-times
reduced level of DNMT1 transcription. These data confirmed the
gene deletion at the DNMT1 gene in these cells and suggest
Figure 1. Clustering analysis of epigenetic profiles of genes located on chr19. Individual genes are indicated by single vertical lines
depicting the epigenetic status from the 5’ end (top) to the 3’ end (bottom) of each gene. Each gene body was divided into 20 bins. The 5 kb
upstream of the TSS and 5 kb downstream of the 3’ gene end were divided into 10 bins. The average signal for each single bin is indicated. Green, red
and black colors represent low, high and average occupation by epigenetic marks in comparison to the average signal on the chromosome,
respectively. Zinc finger (ZNF) genes represent a unique epigenetic class.
doi:10.1371/journal.pone.0018844.g001
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DNMT1 protein [35,36].
DNA methylation profiles of chr19 for HCT116-WT and
HCT116-DKO cells confirmed reduction of DNA methylation in
DKO cells in promoters and in gene bodies (Figure 4). However,
we observed that some genes harboring H3K36me3 retained
substantial DNA methylation levels in the gene body in the DKO
cell line (Figure 4A,D), perhaps related to activity provided by
DNMT3A, which recently has been linked to intragenic DNA
methylation [37]. Specific knockout lines for DNMT3A are not
available and our attempts to knock down DNMT3A using siRNA
were not successful. For a small group of active genes, DNA
methylation was almost not affected in the gene body in HCT116-
DKO cells. These data were confirmed for the POLD1 and
NFKBIB genes by COBRA, which showed remaining DNA
methylation in gene bodies (Figure S5C). DNA methylation
analysis in promoter areas indicated that a group of promoters
drastically lost DNA methylation in HCT116-DKO cells
(Figure 4A,C). However, this fact only infrequently correlated
with transcriptional activation. Importantly, for genes with
substantial gene body DNA methylation, transcription and
H3K36me3 occupancy were not changed in condition of partial
or intensive loss of DNA methylation along the gene bodies in the
HCT116-DKO cell line (Figure 4A,D,E).
We performed composite profile analysis of H3K36me3 and
DNA methylation for the group of genes, which carry both of
these marks in HCT116-WT cells (Figure 4D). This profile
indicated that DNA methylation mimics H3K36me3 over gene
Figure 2. Crosstalk between DNA methylation and chromatin modifications on chr19 in human bronchial epithelial cells. A. Gene
bodies are marked by DNA methylation and H3K36me3 on human chr19 in HBEC. The numbers of genes with gene bodies marked by H3K36me3,
DNA methylation or both, with at least 20% of gene body length covered by the respective mark, are indicated (p,0.001; Chi square test).
B. Representative epigenetic profile of genes harboring DNA methylation and H3K36me3 in the gene body. Signals plotted as negative log10(p-
values) are shown for the chromatin marks H3K9me3, H3K27me3 and H3K36me3. Methylated CpG density mapped by MIRA is shown along with the
mapping of unmethylated CpGs by UnmethylCollector (UMC) C. Composite profile of genes with gene bodies marked by H3K36me3 and DNA
methylation over at least 20% of gene body length. Each gene body was divided into 20 bins. Sequences up to 5 kb upstream of the TSS and 5 kb
downstream of the 3’ gene end were divided into 10 bins. Average of occupation for each single bin is indicated. The chromatin marks histone H3
acetylation (K9/K14), H3K9me3, H3K27me3 and H3K36me3 were analyzed along with methylated CpGs (MIRA) and unmethylated CpGs (UMC).
doi:10.1371/journal.pone.0018844.g002
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DNA methylation levels are reduced in DKO cells. Also, we
observed intense DNA methylation around many more transcrip-
tion start sites in HCT116-WT cells in contrast to immortalized
HBEC (Figure 2C and Figure 4D). Double knockout of DNMT1
and DNMT3B resulted in a loss of DNA methylation around
Figure 3. Epigenetic profile of ZNF genes on chr19 in human bronchial epithelial cells. A. Genes located on chr19 sorted by CpG density
in gene bodies and by percentage of gene body length covered by H3K9me3. B. Distribution of ZNF genes in the human genome. The number of
ZNF genes on individual chromosomes is shown. C. Representative epigenetic profile of ZNF genes. Gene names, directions of transcription and gene
coordinates on the chromosome are indicated. Note the simultaneous occupation of ZNF gene bodies by H3K9me3 and H3K36me3. D. Composite
profile of genes with gene bodies marked by H3K36me3 and H3K9me3 over at least 20% of gene body length. Each gene body was divided into 20
and the 5 kb upstream of the TSS and 5 kb downstream of the 3’ gene end were divided into 10 bins. The average signal for each single bin is
indicated. E. Gene bodies marked by H3K9me3 and H3K36me3 on human chr19 in HBEC. The number of genes with gene bodies marked by
H3K36me3 or H3K9me3 or by both marks over at least 20% of gene body length is shown (p=0.02; Chi square test). Ninety percent of the dual-
occupied genes are zinc finger genes. F. Genes marked by H3K36me3 on chr19 in HBEC. The diagram represents the distribution of H3K9me3 and
DNA methylation in gene bodies containing H3K36me3. Genes were assumed to carry a specific modification if at least 20% of gene body length was
covered by the analyzed mark. Co-occupancy of H3K9me3 and H3K36me3 is a hallmark of ZNF genes.
doi:10.1371/journal.pone.0018844.g003
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PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e18844Figure 4. Epigenetic changes in HCT116-DKO cells. A. Clustering analysis of epigenetic changes on chr19 in HCT116-DKO cells in comparison
to HCT116-WT cells. Each vertical line represents one gene. Green, red and black colors represent low, high and average occupation by epigenetic
marks, respectively, in comparison to the average signal along the chromosome. Similarly, gene expression is indicated by green, red and black color
showing low, high and average expression level, respectively, in comparison to average transcription levels on chr19. For expression changes, red,
green and black colors represent activation, repression and no change of transcription activity, respectively, in HCT116-DKO cells in comparison to
HCT116-WT cells. Abbreviations WT and DKO are for HCT116-WT and HCT116-DKO cells, respectively. B. Interrelation between genome-wide
expression changes in HCT116-DKO cells in comparison to HCT116-WT cells and gene body CpG density (R=-0.02, p = 0.03). Red color indicates ZNF
genes. C. Representative epigenetic profiles of activated ZNF genes in HCT116-DKO and silent state of these genes in HCT116-WT cells. Direction of
transcription and gene coordinates on chromosome 19 are indicated. The boxes span promoters of genes that become demethylated and
reactivated in DKO cells as indicated by appearance of the H3K36me3 mark in their gene bodies. D. Composite profile of H3K36me3-associated genes
in HCT116-DKO and in HCT116-WT cells. The profile was created for genes with gene bodies covered by H3K36me3 and DNA methylation with at
least 20% of gene body length covered in HCT116-WT cells. Each gene body was divided into 20 bins and the 5 kb upstream of the TSS and 5 kb
downstream of the 3’ gene end were divided into 10 bins. The average signal for each single bin is indicated. E. H3K36me3 is not lost in regions with
extensive loss of DNA methylation in gene bodies. Despite of loss of DNA methylation (blue tracks) in gene bodies, the H3K36 profile (black tracks) is
almost unaltered.
doi:10.1371/journal.pone.0018844.g004
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bodies (Figure 4C,D). It is important to point out that H3K36me3
levels were not specifically affected in genes with intensive loss of
DNA methylation in the gene body (Figure 4D,E).
ZNF genes become activated due to reduction of DNMT
activities
According to data on transcriptional changes obtained from
Affymetrix exon arrays, almost only ZNF genes became activated
on chr19 in the HCT116-DKO cell line (Figure 4A). This fact was
associated with de novo H3K36me3 occupation of gene bodies and
promoter DNA demethylation in HCT116-DKO cells (Figure 4C).
Since ZNF genes are localized in H3K9me3-occupied areas in
HBEC, we profiled this mark in HCT116-WT and HCT116-
DKO cells. We observed that activation of ZNF genes is associated
with a reduction of the H3K9me3 mark in promoter areas and in
gene bodies (Figure 4C). Further analysis indicated that de novo
H3K36me3 occupation in HCT116-DKO cells is typical for low
CpG density gene bodies. Since H3K36me3 is highly correlated
with transcriptional activity, we plotted transcription activity
changes in HCT116 DKO relative to WT cells versus CpG
density in gene bodies, genome-wide, by using results from
Affymetrix exon arrays (Figure 4B). Our data indicate that gene
activation occurs more frequently than silencing in HCT116-
DKO cells. Transcriptional upregulation in HCT116-DKO versus
HCT116-WT cells was almost specific for genes with low CpG
density in gene bodies. Also, the level of transcriptional change is
gradually decreasing with increase of CpG density in gene bodies
(Figure 4B). These data are correlated with relatively rare changes
in the H3K36me3 profile in HCT116-DKO cells and infrequent
transcriptional changes observed on chr19 (Figure 4A). We
performed composite profile analysis for activated genes bearing
H3K9me3 in gene bodies in HCT116-DKO cells (Figure S6A).
These data confirmed our observation about the mechanism of
ZNF gene activation and showed that gene activation of
H3K9me3-covered genes is associated with an increase of
H3K36me3 in the gene body, a decrease of H3K9me3 in the
promoter and gene body, and loss of DNA methylation at the
promoter. On the other hand, repression of H3K9me3-covered
genes is associated with a slight increase of H3K9me3 level at the
promoter area and loss of H3K36me3 (Figure S6B).
DNA methylation is not affected by reduction of
H3K36me3 levels
To understand if the H3K36me3 mark plays a role in the
establishment and maintenance of intragenic DNA methylation
patterns, we decreased the level of this chromatin modification in
cells to monitor possible changes of DNA methylation and
transcriptional activity. Towards this goal, we performed trans-
fection experiments with siRNA for SETD2, the major
H3K36me3 methyltransferase [25], in HBEC cells and in
HCT116-DKO cells. According to our Western blotting data,
H3K36me3 levels were drastically reduced in SETD2 siRNA
treated HBEC in comparison to non-targeting siRNA transfected
cells (Figure 5A). Expression analysis by Affymetrix exon arrays
indicated that 304 genes underwent transcriptional changes due to
SETD2 siRNA treatment. Of these, 209 genes were significantly
repressed due to SETD2 siRNA transfection. From these genes, 17
genes were localized on chr19 including 10 ZNF genes. Genome-
wide, transcription of 20 ZNF genes was affected due to SETD2
knockdown usually showing repressed transcriptional activity.
Since a much higher number of genes sustain a decrease of
H3K36me3 levels according to ChIP on ChIP data than the
number of genes showing transcriptional changes in SETD2
siRNA experiments, we assume that the H3K36me3 mark is not
chiefly involved in maintaining transcript levels.
We performed composite profile analysis of gene bodies in
SETD2 siRNA treated cells versus controls (Figure 5B). These
data confirmed a reduction of H3K36me3 levels after siSETD2
treatment. Our data did not show a reduction of DNA
methylation levels in gene bodies. Importantly, we verified the
DNA methylation status for several genes with substantial loss of
H3K36me3 levels in gene bodies according to the microarray
results. Our COBRA analysis and bisulfite sequencing did not
identify a reduction of DNA methylation after siRNA for SETD2
versus non-targeting siRNA (Figure 5C,D) (p=0.276; Fisher’s
exact test, two-tailed, for bisulfite data). Further, we tried to
identify a possible role of H3K36me3 under conditions of DNMT
deficiency in HCT116-DKO cells. Similar to HBEC, we treated
HCT116-DKO cells with SETD2 siRNA for five days. This
experiment resulted in significant loss of H3K36me3 (Figure 5E).
However, we could not observe a reduction of DNA methylation
in SETD2 siRNA treated cells (Figure 5F) (p=1.000; Fisher’s
exact test, two-tailed). Based on these observations, we conclude
that DNA methylation patterns in gene bodies are established
independently of the H3K36me3 mark.
Discussion
In our study, we observed that the H3K36me3 mark reflects
active transcription. These results support previous genome-wide
mapping data of this histone modification, observations of
H3K36me3 as a mark for the transcription elongation process and
direct interaction of SETD2 with hyperphosphorylated RNA
polymerase II [25,38,39]. According to our detailed analysis of
chromosome 19, H3K36me3 presence is clearly correlated with
DNA methylation levels in gene bodies. Similar results reporting
correlations of H3K36me3, transcript levels, and gene body DNA
methylation were obtained in IMR90 cells, in human embryonic
stem cells and in human B-lymphocytes [20,22,24]. Our results also
indicate that absence of H3K36me3 is associated with partial
methylationorhypomethylationstatusofgenebodyDNA(Figure1).
The correlation between DNA methylation and H3K36me3 in
gene bodies was also investigated in HCT116-DKO cells lacking
DNA methyltransferases. In HCT116-DKO cells, we observed a
slight reduction of total H3K36me3 levels compared to HCT116-
WT cells but independent of DNA methylation changes. This
observation can be explained by the fact that H3K36me3 levels
are associated with the cell cycle and that HCT116-DKO cells
proliferate more slowly than HCT116-WT cells [40,41]. However,
we did not observe any substantial loss of H3K36me3 in genes
with intensive loss of DNA methylation in HCT116-DKO cells
(Figure 4). Reduction of H3K36me3 levels by siRNA-mediated
knockdown of SETD2 rarely affected transcriptional activity (only
304 genes genome-wide were significantly affected in these
experiments). H3K36me3 loss failed to reduce DNA methylation
in gene bodies in both HBEC and HCT116-DKO cells (Figure 5).
These data suggest that DNA methylation and H3K36me3 are not
associated directly and that both marks are established indepen-
dently during the transcription elongation process. Our data are
not directly consistent with recent observations showing an
interaction of the PWWP domain of DNMT3A with the
H3K36me3 modification [42]. In our hands, the loss of
H3K36me3 did not result in noticeable reduction of DNA
methylation in HBEC or in HCT116-DKO cells. Since presence
of active DNMT1 and DNMT3B in HBEC could make it difficult
to detect a loss of DNA methylation caused by absence of
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HCT116-DKO cells lacking both DNMT1 and DNMT3B but
retaining DNMT3A. We assumed that an effect of H3K36me3 on
DNMT3A and DNA methylation would be enhanced in
conditions of absence DNMT3B and in presence of reduced
levels of truncated DNMT1. However, reduction of H3K36me3 in
these cells did not result in loss of DNA methylation either.
Nonetheless, it is possible that the low amounts of H3K36me3
remaining after SETD2 knockdown may still suffice for maintain-
ing DNA methylation.
Since gene body DNA methylation and H3K36me3 are
correlated, yet not directly dependent on each other, we assume
that both marks are established independently during the
transcription elongation process. SETD2 is a component of
transcription elongation complexes and binds to RNA polymerase
II [26,27]. Whether the DNA methylation machinery is similarly
connected to elongating RNA polymerase II complexes remains to
be determined but there is evidence from plants describing
proteins that interact with RNA polymerase II and function in
RNA-directed DNA methylation [43,44].
We found that H3K9me3 is mostly associated with genes
characterized by low CpG density in the gene body. The reason
for the association of low CpG density genes with H3K9me3 is
unclear. We assume that genes with low CpG density in the gene
Figure 5. Epigenetic changes after SETD2 knockdown. A. Western blot for HBEC cells after non-targeting siRNA and SETD2 siRNA transfection
using anti-H3K36me3 antibodies and unmodified histone H3 antibodies. B. Composite profile of epigenetic changes after SETD2 siRNA knockdown in
HBEC. The profile was created for gene bodies marked by H3K36me3 and DNA methylation over at least 20% of gene body length. Each gene body
was divided into 20 bins and the 5 kb upstream of the TSS and 5 kb downstream of the 3’ gene end were divided into 10 bins. The average signal for
each single bin is indicated. C. Analysis of DNA methylation in the gene body of the NOTCH3 gene in conditions of H3K36me3 deficiency. The
H3K36me3 profile of NOTCH3 after non-targeting siRNA and SETD2 siRNA transfections in HBEC cells is shown. The region analyzed by COBRA
methylation assays is indicated by a box. Using gene-specific primers, bisulfite-converted DNA was amplified. After cutting with HpyCH4IV
recognizing CpG dinucleotides, mock (-) and enzyme-digested (+) PCR products were fractionated on a 2% agarose gel. In vitro CpG-methylated
human DNA (M) served as a positive control. Cleavage indicates DNA methylation. D. Analysis of H3K36me3 and DNA methylation in the gene body
of RFX2 in conditions of H3K36me3 deficiency. The region analyzed by bisulfite sequencing is marked by a box. Using gene-specific primers, bisulfite-
converted DNA was amplified, cloned and 20 individual clones were sequenced. White circles, unmethylated CpG sequences; black circles,
methylated CpG sequences. E. Western blot for HCT116-DKO cells after non-targeting siRNA and SETD2 siRNA transfection using anti-H3K36me3
antibodies and unmodified histone H3 antibodies. F. DNA methylation analysis of the gene body of NOTCH3 after non-targeting siRNA and SETD2
siRNA transfection of HCT116-DKO cells. Using gene-specific primers, bisulfite-converted DNA was amplified, cloned and 13 individual clones were
sequenced. White circles, unmethylated CpG sequences; black circles, methylated CpG sequences.
doi:10.1371/journal.pone.0018844.g005
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cells, almost only low CpG density genes became activated in
conditions of DNMT deficiency. It appears that genes having high
levels of CpG methylation in both the promoter and the gene body
are difficult to reactivate by loss of DNA methylation. Similar to
DNA methylation, which is present in gene bodies of many genes,
the H3K9me3 mark covers preferentially ZNF genes intrageni-
cally. The functional role of the H3K9me3 histone modification in
gene bodies is currently unknown, as is the function of DNA
methylation in gene bodies. Like DNA methylation, H3K9me3 is
generally considered a repressive mark and is usually associated
with compacted chromatin. It was suggested that DNA methyl-
ation in gene bodies may block false initiation of transcription
[18,22]. We propose that H3K9me3 may play a similar role in
gene bodies and replaces the intragenic function of DNA
methylation under conditions of low CpG density. Unlike genes
with intragenic DNA methylation, which are associated with
intermediate to high levels of transcription [22], genes with
H3K9me3 in the gene body are associated with very low levels of
transcription. We suppose that H3K9me3 may slow down RNA
polymerase II much more effectively than DNA methylation in
gene bodies. This fact may be reflected in low levels of ZNF
transcripts.
We observed that ZNF genes are characterized by H3K9me3
and H3K36me3 dual occupation and by very low CpG density in
gene bodies. This specific feature was associated with activation of
this group of genes in conditions of DNMT deficiency. ZNF genes
were previously separated as a group of genes associated with
H3K9me3 in the promoter [24]. Also, the regulation of ZNF genes
was linked to the KAP1 factor, which is mostly associated with 3’
gene ends and repression of ZNF genes [46,47]. These facts also
indicate ZNF genes as a separate epigenetic group. The
observations suggest that functionally related genes can be divided
into groups with specific epigenetic marks.
In conclusion, the two main findings of our study are that (i) the
H3K36me3 and DNA CpG methylation patterns in gene bodies
are not directly dependent on each other, and (ii) from their CpG
density-dependent gene-specific localization patterns, we suggest
that there is a similar functional role for intragenic DNA
methylation and intragenic H3K9me3 for CpG-rich and CpG-
poor genes, respectively. Future studies will determine whether the
role of these two intragenic repressive marks indeed lies in
suppression of spurious intragenic gene transcription as is assumed
by some current models or whether they have other functional
roles that are currently not anticipated.
Materials and Methods
Tissue culture, siRNA transfection and Western blot
HCT116-WT and HCT116-DKO (DKO1 line) cells were
generous gifts from B. Vogelstein (Johns Hopkins University) [30].
These cells were cultured in McCoy’s 5A medium with 10% FBS.
Bronchial epithelial cells immortalized with hTERT and Cdk4
were kindly provided by John D. Minna (The University of Texas
Southwestern Medical Center). The immortalization and culturing
conditions for HBEC have been described previously [31].
For siRNA treatment, cells were transfected twice, 96 hours
apart, each transfection using Lipofectamine 2000 (Invitrogen) and
OptiMEMH I medium (Invitrogen) according to the manufactur-
ers’ instructions. For the SETD2 gene, we used siRNA D-012448-
03, HYPB (Dharmacon). For non-targeting control, siRNA D-
001810-01-05 was used (Dharmacon).
For protein analysis, the same number of cells for control and
SETD2 siRNA experiments were used. Samples were denatured in
Laemmli sample buffer (BioRad; Hercules, CA) and resolved in
pre-cast gels (BioRad). After semi-wet transfer, membranes were
blocked with 5% milk (BioRad) in PBS with 0.1% Triton X-100
and further incubated with specific antibodies. We used the
following antibodies for Western blotting: H3K36me3 (Abcam
and SA Bioscience), histone H3 (Abcam), and beta-actin (Sigma).
Detection was achieved using HRP-conjugated secondary anti-
bodies (BioRad) and ECL Western Blotting System (GE
Healthcare).
Expression analysis
Total RNA was isolated with the RNAeasy kit (Qiagen;
Valencia, CA). For RNA analysis in HBEC, Affymetrix human
gene 1.0-ST arrays were used. For expression profiles of HCT116-
WT, HCT116-DKO, and HBEC non-targeting siRNA and
HBEC SETD2 siRNA experiments, Affymetrix human exon
1.0-ST microarrays were applied. Microarrays were processed at
the City of Hope microarray core facility. Arrays were scanned at
5 mm resolution using the Affymetrix GCS 3000 7G scanner and
GeneChip Operating Software v. 1.4 to produce. CEL intensity
files. Raw intensity measurements of all probe sets were
background-corrected, normalized and converted into transcript
or exon level expression measurements using the Affymetrix
Expression Console v1.1.1. All data is MIAME compliant. The
raw microarray data have been deposited in the Gene Expression
Omnibus repository (accession number GSE26020), which is a
MIAME compliant database, as detailed on the MGED Society
website http://www.mged.org/Workgroups/MIAME/miame.
html. Expression data were verified by real-time RT-PCR with
cDNA obtained with iScript cDNA Synthesis Kit (BioRad).
DNA analysis
DNA isolation was done with the DNAeasy kit according to the
manufacturer’s instructions (Qiagen). Bisulfite DNA conversion
was done with the EZ DNA Methylation-Gold
TM Kit (Zymo
Research; Orange, CA). For DNA methylation analysis, bisulfite-
modified DNA was amplified with FastTaq polymerase (Qiagen)
and gene-specific primers (primer sequences are available on
request). The amplicon was digested dependent on sequence with
TaqIa, BstUI or HpyCH4IV (New England Biolabs; Beverly,
MA), or cloned by using pGEMTeasy vector (Promega; Madison,
WI) and TAM1 competent cells (Active Motif; Carlsbad, CA).
After cloning, individual clones were sequenced.
MBD2B and MBD3L1 protein purification and MIRA were
done as previously described [48]. For MIRA, sonicated genomic
DNA was incubated with the MBD2B/MBD3L1 complex
overnight at 4uC. The methylated DNA fraction was isolated by
magnetic GST beads (Promega) and washed with MIRA washing
buffer containing 700 mM NaCl. DNA was extracted by adding
binding buffer from the PCR purification kit (Qiagen) and cleaned
by using PCR purification kit according to the manufacturer’s
instructions. Profiling of unmethylated DNA was done with the
UnMethylCollector kit (Active Motif; Carlsbad, CA) according to
the manufacturer’s instructions. This kit uses the CXXC domain
of the MBD1 protein for enrichment of unmethylated DNA.
Enriched unmethylated DNA and input fractions were processed
for microarray hybridization similar as described for the MIRA
protocol [48]. For genome amplification, DNA was incubated with
T4 DNA polymerase (New England Biolabs) for 20 minutes at
12uC, purified with PCR purification kits and ligated with blunt
end linker (5’-AGCAACTGTGCTATCCGAGGGAT and 5’-
ATCCCTCGGA) overnight at 16uC with T4 ligase (New England
Biolabs). Genome amplification was performed in the exponential
phase with Taq polymerase (Qiagen). For MIRA quality control,
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(Qiagen) was done by using specific primers complementary to
unmethylated gene promoters (TBP, GAPDH) or methylated
targets (H19, SNPRN, TGM3 gene body). Primer sequences are
available on request. For DNA methylation and chromatin
profiling, NimbleGen tiling microarrays of human chromosome
19 were used. Labeling, hybridization, and scanning of Nimble-
Gen tiling arrays were performed at the City of Hope microarray
core facility. The log2 ratios of MIRA signal vs. input were
generated using NimbleScan v 5.0 (NimbleGen) with default
settings. All microarray data is MIAME compliant. The raw
microarray data have been deposited in the Gene Expression
Omnibus repository (accession number GSE26020), which is a
MIAME compliant database, as detailed on the MGED Society
website http://www.mged.org/Workgroups/MIAME/miame.html.
Chromatin immunoprecipitation (ChIP)
ChIP experiments were done as previously described [6]. In our
experiments, we used the following antibodies: normal rabbit IgG
(sc-2027, Santa Cruz Biotechnology, Inc.), anti-H3K36me3
(ab9050, Abcam), anti-H3K9me3 (07-442, Millipore), anti-ace-
tyl-histone H3 (K9 and K14) (06-599, Millipore), anti-H3K4me3
(07-473, Millipore) and anti-H3K27me3 (07-449 Milipore). These
antibodies have been verified and used previously in epigenome
mapping studies [24,25,49,50,51,52,53].
Profiles at the gene body and promoter
The hg18 RefSeq database (http://hgdownload.cse.ucsc.edu/
goldenPath/hg18/database/) was used for annotation. The
promoter region was defined as +/2500 bp relative to the
transcription start site, and ‘gene body’ was defined as from the
transcription start site to the end of the transcript. For DNA
methylation and histone modifications, the average log2 ratios of
probes falling into promoters or gene bodies were calculated. For
CpG count in the gene body, the number of CpG dinucleotides
within gene bodies was counted and divided by the length of the
gene body and then scaled to counts per 1 kb.
Gene body methylation and histone mark coverage
The probes with log2 ratio .1 were considered as positive. The
gene body coverage for each gene in the hg18 RefSeq database was
represented by the percentage of positive probes within its gene
body. To identify the genes covered by multiple marks, the genes
with .=20% positive probe coverage for each mark were identified
and then the gene symbols were matched across multiple marks.
Composite profiles
The gene body for each RefSeq gene was divided into 20 equal-
sized bins, and its 5 kb upstream and downstream region was
divided into 10 equal-sized bins each. For each bin of each gene,
the probes falling into the bin were retrieved and their log2 ratio
for each marker was averaged to represent its signal within that bin
of the gene. For each bin, the average probe signal of each marker
for all the genes are then averaged and plotted. The signals were
used either for heatmap directly (Figure 1) or averaged for
composite profile generation (e.g., Figure 3D).
Exon-level analysis
Exon level intensity data were obtained using the RMA method
of Partek Genomic Suite v6.5 (Partek; St. Louis, MO), and those
located on chr19 were kept for subsequent analysis. The top 15%
exons with the highest expression level and bottom 15% exons
with the lowest expression level were selected based on their log2
intensity distribution, and denoted as exons with high and low
expression, respectively. For the genes covered with either
H3K36m3 and MIRA signal or with H3K36m3 and H3K9m3
signal, the average log2 ratio signal of the probes falling into the
two expression categories were calculated. For genes with at least
two exons, the average log2 ratio signal of the probes falling into
the first exon, last exon, and each intron were calculated. For the
genes on chr19 with at least two coding exons, the average log2
ratio signal of the probes falling into the first coding exon and last
coding exon were calculated. The distribution of these average
probe signals was presented as boxplots (Figure S4).
Gene ontology analysis
The gene lists were uploaded to DAVID functional annotation
tools (http://david.abcc.ncifcrf.gov/) and genes on chr19 were
used as background.
Supporting Information
Figure S1 Interrelationship between DNA methylation
and the H3K36me3 modification. A. The DNA methylation
level is dropping after the 39 gene end of an H3K36me3-occupied
gene. The DNA methylation status of the 39 gene end and the
neighboring region was analyzed for the LSM gene in HBEC cells.
DNA methylation and H3K36me3 microarray profiles are shown.
Direction of transcription, gene coordinates and locations of the
COBRA-analyzed regions (blue boxes) are indicated. Using gene-
specific primers, bisulfite-converted DNA was amplified. After
cutting with TaqIa, recognizing CpG dinucleotides, mock (-) and
enzyme-digested (+) PCR products were separated on a 2%
agarose gel. In vitro CpG-methylated human DNA (M) served
as a positive control. Cleavage indicates DNA methylation.
B. COBRA analysis of an intragenic region of the POLD1 gene
showing DNA methylation and H3K36me3 occupancy. The
analyzed region is indicated by a blue box. C. COBRA analysis of
an intragenic region of the NFKBIB gene showing DNA
methylation and H3K36me3 occupancy. The analyzed region is
indicated by a blue box. D. Negative correlation between
unmethylated DNA (UMC) and H3K36me3 in HBEC. Averages
of UMC signal in the gene body for each gene were spotted versus
average of H3K36me3 signal in the gene body. E. Positive
correlation between methylated DNA (MIRA) and H3K36me3 in
HBEC. Averages of MIRA signal in the gene body of each gene
were spotted versus average of H3K36me3 signal in the gene
body. F. Negative correlation between histone H3 acetylation
(H3Ac) and DNA methylation (MIRA) in promoters (-1000 to
+500 bp of the transcription start sites). G. Negative correlation
between unmethylated DNA signal (UMC) and methylated DNA
signal (MIRA) in promoters.
(PDF)
Figure S2 Crosstalk between DNA methylation and
H3K27me3 in HBEC. A. Gene bodies marked by DNA
methylation and H3K27me3 on human chr19 in HBEC. The
numbers indicate genes with gene bodies marked by H3K27me3
or DNA methylation or by both marks with at least 20% of gene
body length coverage (p,0.001; Chi square test). B. Composite
profile of genes with gene bodies marked by H3K27me3 and DNA
methylation with at least 20% of gene body length coverage. Each
gene body was divided into 20 bins and the 5 kb upstream of the
TSS and 5 kb downstream of the 39 gene end were divided into 10
bins. The average signal for each single bin is plotted. Both MIRA
and UMC signals are enriched within H3K27me3-covered gene
bodies indicating partial methylation. C. Representative epigenetic
profile of a chr19 region containing H3K27me3-marked genes
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different epigenetic gene groups, genes marked by H3K27me3
together with DNA methylation, genes marked by H3K9me3 and
H3K36me3, and genes marked by DNA methylation together
with H3K36me3. The average of signal in each gene body was
plotted for each epigenetic group. A gene was considered marked
by a specific epigenetic modification if this mark was present along
at least 20% of gene body length. Multiple comparison tests show
that all three pairs show statistical difference at p,0.001. E. CpG
density in gene bodies for genes marked by H3K27me3 and DNA
methylation, by H3K9me3 and H3K36me3, and by DNA
methylation together with H3K36me3. Average of CpG density
for each gene body was plotted for each epigenetic group.
Comparison between H3K27me3-MIRA and H3K36me3-
H3K9me3 shows statistical difference (p,0.001). Comparison
between H3K36me3-MIRA and H3K36me3-H3K9me3 also
shows statistical difference (p,0.001). There is no statistical
difference between H3K27me3-MIRA and H3K36me3-MIRA
(p.0.05).
(PDF)
Figure S3 Epigenetic characteristics of H3K9me3-asso-
ciated genes on chr19 in HBEC. A. Partial DNA methylation
in gene bodies of genes occupied with H3K9me3. A representative
epigenetic profile of an H3K9me3-enriched gene is shown.
Direction of transcription, gene coordinates and the region
analyzed by COBRA in the NAPL1 gene are indicated. DNA
methylation analysis was performed by COBRA for three CpG-
poor and H3K9me3-occupied genes (NALP1, UNC13A, and
ZNF536) with partial DNA methylation as indicated by UMC
signal. In vitro CpG-methylated human DNA (M) served as a
positive control. Cleavage indicates DNA methylation. B. Gene
ontology terms associated with H3K9me3- and H3K36me3 dual-
occupied genes according to analysis via DAVID.
(PDF)
Figure S4 Gene body DNA modifications and chromatin
marks in relation to exon and intron structure. Genes on
chromsome 19 were subdivided into two categories. Panels A and
B show genes co-occupied with H3K36me3 and DNA methyla-
tion. Panels C and D represent genes co-occupied with
H3K36me3 and H3K9me3. Using data from Affymetrix exon
arrays, we determined which exons are expressed at low levels
(bottom 15% of expressed genes) and which ones are expressed at
high levels (top 15% of expressed genes). The MIRA, H3K36m3
or H3K9m3 average signal (log2 ratio) of probes in the selected
exons or introns is plotted. We also plotted the signals for the
first and last exons and the first and last coding exons, respectively.
A. H3K36me3 levels in H3K36me3 and DNA methylation co-
occupied genes. B DNA methylation levels in H3K36me3 and
DNA methylation co-occupied genes. C. H3K36me3 levels in
H3K36me3 and H3K9me3 co-occupied genes. A. H3K9me3
levels in H3K36me3 and H3K9me3 co-occupied genes.
(PDF)
Figure S5 DNA methylation and epigenetic profiles in
HCT116-DKO and HCT116-WT cells. A. DNA methylation
in LINE1 elements in HCT116-DKO and HCT116-WT cells.
Using LINE1-promoter-specific primers, bisulfite-converted DNA
was amplified. After cutting with HinfI, recognizing CpG
dinucleotides, mock (-) and enzyme-digested (+) PCR products
were fractionated by size on a 2% agarose gel. In vitro CpG-
methylated human DNA (M) served as a positive control.
Cleavage indicates DNA methylation, which is almost completely
lost in DKO cells B. MIRA and H3K36me3 distribution profile
along the DNMT1 gene in HCT116-DKO and HCT116-WT
cells. Note the loss of signal between exons 3 and 5 (yellow box) in
DKO cells due to gene disruption but persistent transcription as
indicated by the H3K36me3 profile. C. Verification of retained
DNA methylation in some gene bodies in HCT116-DKO cells.
Representative profile of persistent DNA methylation in gene
bodies in HCT116-DKO cells and comparison to the profile in
HCT116-WT cells. Red, DNA methylation; green, H3K36me3.
The gene coordinates and location of the analyzed region in the
NFKBIB gene are indicated. DNA methylation analysis was
performed by COBRA for two different genes retaining DNA
methylation in the gene body according to the MIRA data. Using
gene-specific primers, bisulfite-converted DNA was amplified.
After cutting with TaqIa, recognizing CpG dinucleotides, mock (-)
and enzyme-digested (+) PCR products were fractionated by size
on a 2% agarose gel. In vitro CpG-methylated human DNA (M)
served as a positive control. Cleavage indicates DNA methylation.
(PDF)
Figure S6 Epigenetic profiles of H3K9me3-associated
genes that are either upregulated or downregulated in
HCT116-DKO cells. A. Composite profile of upregulated
H3K9me3-covered genes in HCT116-WT and DKO cells. The
profile was created for genes with gene bodies covered by
H3K9me3 with at least 20% of gene body length coverage in
HCT116-WT cells and upregulated transcription by at least log2
of 0.5 in comparison to HCT116-WT cells. B. Composite profile
of downregulated H3K9me3 genes in HCT116-DKO. The profile
was created for genes with gene bodies covered by H3K9me3 with
at least 20% of gene body length coverage in HCT116-WT cells
and downregulated transcription by at least log2 of 0.5 in
comparison to HCT116-WT cells.
(PDF)
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